Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stopping proton-pump inhibitor treatment in patients with liver cirrhosis
2019-005008-16Phase 3Active
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Cirrhosis comparing PPI discontinuation / placebo with PPI continuation / esomeprazole (2 arms). Primary endpoint: Time to unplanned rehospitalization or death. Started Aug 2020; status: active.
02
Drugs
esomeprazole
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on 2019-005008-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-005008-16.